C1q induced activation of MAPKs and PI3K/Akt signaling, and increased MMP2 and MMP9 expressions, strongly suggesting C1q–DDR1 interactions in the progression of HCC (187). The gene discussed is MMP2; the disease is hepatocellular carcinoma.